Davita

DVA · NYSE · USD

178,69 $Variation par rapport à la clôture précédente: +1,33 %Variation absolue: +2,34 $

Clôture · 2 octobre 2026

Profil de la société

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Description disponible en anglais.

Informations sur la société

Secteur
Santé
Industrie
Medical Care Facilities
Siège
2000 16th Street, 80202, Denver
Salariés
78 000
Cotation
DVA · NYSE
Indices
S&P 500
Devise
USD
ISIN
US23918K1088
Site web
davita.com